5 lessons as COVID-19 unfolds for future pandemics – Insights from the biopharmaceutical industry
Thomas Cueni, Director General of IFPMA, participated in the Science and Technology in Society Forum (STS Forum) on 4th October 2020, in a session titled “Improving Preparedness for Pandemic Diseases: the Role of Science and Technology”. Other speakers included PeggyHamburg (former Commissioner, US FDA, Prof. Yamanaka (Nobel Laureate 2012), and Prof. Tan from (Ministry of Health Singapore). On this occasion, he has recorded a video “5 lessons as COVID-19 unfolds for future pandemics – Insights from the biopharmaceutical industry”, highlighting the importance of applying basic science and basic research into scalable solutions, scalable treatments and vaccines for patients, and explaining the advantages of mRNA technology and monoclonal antibodies (mAbs).
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
